Chemokines as Potential Therapeutic Targets in Atherosclerosis
Journal:
Current Drug Targets
Volume:
7
Page:
13-27
Author(s):
Y. A. Sheikine and G. K. Hansson
Pharmacotherapy of Schizophrenia: The Past, Present and Future
Journal:
Current Drug Therapy
Volume:
1
Page:
1-7
Author(s):
Shahin Akhondzadeh
Cerebral White Matter Lesions, Risk of Stroke and Cerebrovascular Protection with Angiotensin Receptor Blockers
Journal:
Current Drug Therapy
Volume:
1
Page:
9-16
Author(s):
Alejandro d. l. Sierra and Cristina Sierra
Ovulation Induction in Anovulatory Patients with Polycystic Ovary Syndrome
Journal:
Current Drug Therapy
Volume:
1
Page:
23-29
Author(s):
Stefano Palomba, Angela Falbo, Tiziana Russo and Fulvio Zullo
The Effects of Soy Isoflavones in Postmenopausal Women: Clinical Review
Journal:
Current Drug Therapy
Volume:
1
Page:
31-36
Author(s):
Eliana A P. Nahas and Jorge Nahas-Neto
Role of Angiotensin-1-Receptor Blockers In Cardiorenal Disease
Journal:
Current Drug Therapy
Volume:
1
Page:
47-54
Author(s):
Rene R. Wenzel
Clinical Pharmacology of Cyclophosphamide and Ifosfamide
Journal:
Current Drug Therapy
Volume:
1
Page:
55-84
Author(s):
Jing Zhang, Quan Tian and Shu-Feng Zhou
Imidazoline Receptors, Novel Agents and Therapeutic Potential
Journal:
Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume:
4
Page:
17-32
Author(s):
G. A. Head and D. N. Mayorov
Recent Developments in the Design of Orally Bioavailable β3-Adrenergic Receptor Agonists
Journal:
Current Medicinal Chemistry
Volume:
13
Page:
25-37
Author(s):
Masaaki Sawa and Hiroshi Harada
Heptahelical and Other G-Protein-Coupled Receptors (GPCRs) Signaling
Journal:
Current Medicinal Chemistry
Volume:
13
Page:
51-63
Author(s):
Y. Landry, N. Niederhoffer, E. Sick and J. P. Gies